Treatment of vulvovaginal dryness: The benefits of a OTC hormone-free cream vs. an oestrogen-containing cream

Subpage image
Loading

Treatment of vulvovaginal dryness: The benefits of a OTC hormone-free cream vs. an oestrogen-containing cream

07 Oct 2019
PUBLIC HEALTH & WELLBEING THEATRE
Nearly 1 in 2 women in middle age and above have experienced vaginal dryness. Aside from bothersome subjective symptoms – dryness, burning, itching and pain independent of sexual intercourse – the condition can have a huge impact on quality of life. Speaker, Dr Dawn Harper will be sharing her views on scientific findings regarding the non-inferiority of an OTC hormone-free cream vs. a 0.1 % estriol-containing cream in the treatment of vulvovaginal dryness symptoms in postmenopausal women. In a multicentre open-label randomised controlled trial the non-hormonal, moisturising cream showed no statistically significant difference to the estriol-containing cream regarding improvement of subjective symptoms and daily life impairment. Further, more adverse events were related to vaginal estriol than to moisturising cream. Thus, a non-hormonal vaginal moisturising cream significantly improves postmenopausal vulvovaginal atrophy symptoms and may be used as first-line treatment for vulvovaginal atrophy in accordance with the recommendations of the North American Menopause Society

In association with

Pfizer

Supported by

Education Partners

Sponsored by

Charity Partner

Official Media Partner


CIG

Official Publications

Digital Media Partner


C+D

Natural Education Partner

Natural Pharmacy Business

Media partners